Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program".
- Sponsor
- Rep. Castor, Kathy [D-FL-14]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jun 18, 2026
Bottom line
This resolution uses the Congressional Review Act to block a specific CMS rule related to Affordable Care Act benefit and payment parameters for 2027, preventing its implementation.
What it actually does
This joint resolution, introduced under the Congressional Review Act (CRA), seeks to nullify a final rule issued by the Centers for Medicare & Medicaid Services (CMS) within the Department of Health and Human Services (HHS). The rule in question pertains to the "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program." If enacted, H.J. Res. 197 would prevent the CMS rule from taking effect, effectively blocking its provisions for the 2027 plan year and potentially beyond.
Proponents argue
Proponents of this resolution would argue that the CMS rule oversteps its authority, imposes undue burdens, or negatively impacts consumers or healthcare providers in ways that Congress did not intend. They might assert that the rule introduces unfavorable changes to ACA benefit designs, payment structures, or the Basic Health Program, necessitating congressional intervention to protect stakeholders and ensure the stability and affordability of healthcare coverage.
Opponents contend
Opponents of this resolution (and by extension, proponents of the CMS rule) would contend that the rule is a necessary and appropriate regulatory action designed to refine the Affordable Care Act's implementation, ensure market stability, or improve program efficiency for 2027. They would argue that blocking the rule would create uncertainty, disrupt planning for health insurers and states, or undermine efforts to manage healthcare costs and access effectively.
The bill text is extremely short and can be read in under a minute, but understanding its implications requires knowledge of the underlying CMS rule.
Resolved by the Senate and House of Representatives of the United States of America in Congress assembled, That Congress disapproves the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to ``Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program'' (91 Fed. Reg. 29526 (May 20, 2026)), and such rule shall have no force or effect.
Disapproval of CMS Rule on ACA Benefit and Payment Parameters for 2027
This provision explicitly states that Congress disapproves of a specific rule issued by the Centers for Medicare & Medicaid Services (CMS) on May 20, 2026, which was published in the Federal Register (91 Fed. Reg. 29526). The rule concerns the "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program." By disapproving it, the resolution declares that this CMS rule will have no legal standing or effect, preventing its implementation.
Supporters argue
Supporters of this disapproval argue that the CMS rule contains provisions that are detrimental to consumers, impose unnecessary burdens on states or insurers, or deviate from congressional intent regarding the Affordable Care Act. They believe that blocking the rule is essential to protect the integrity of the ACA marketplaces or the Basic Health Program, potentially by preventing changes that could increase costs, reduce benefits, or complicate administration.
Critics contend
Opponents of the disapproval resolution (i.e., those who support the CMS rule) would contend that the rule is a carefully crafted regulatory update necessary to ensure the smooth functioning, stability, and affordability of the ACA marketplaces and the Basic Health Program for 2027. They would argue that blocking the rule would create regulatory gaps, introduce uncertainty, and hinder CMS's ability to adapt to evolving market conditions, potentially leading to adverse outcomes for insurers, states, and consumers.
Tradeoffs
The resolution presents a tension between executive branch regulatory flexibility and congressional oversight. It trades the potential benefits or refinements of the CMS rule for maintaining the status quo or forcing CMS to issue a revised rule, potentially introducing regulatory uncertainty for the 2027 plan year.